Hinova Pharmaceuticals Inc. (SHA:688302)
China
· Delayed Price · Currency is CNY 40.76
-0.20 (-0.49%)
At close: Apr 29, 2026
Hinova Pharmaceuticals Market Cap
Hinova Pharmaceuticals has a market cap or net worth of 4.04 billion as of April 29, 2026. Its market cap has increased by 24.99% in one year.
Market Cap
4.04B
Enterprise Value
3.31B
Revenue
46.50M
Ranking
n/a
PE Ratio
n/a
Stock Price
40.76
Market Cap Chart
Since April 12, 2022, Hinova Pharmaceuticals's market cap has increased from 2.98B to 4.04B, an increase of 35.42%. That is a compound annual growth rate of 7.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 4.06B | -16.70% |
| Dec 31, 2025 | 4.87B | 60.11% |
| Dec 31, 2024 | 3.04B | -41.02% |
| Dec 29, 2023 | 5.16B | 29.14% |
| Dec 30, 2022 | 3.99B | 33.95% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Boji Medical Technology | 4.07B |
| Shanghai Obio Technology (Group) Corp. | 4.23B |
| Baolingbao Biology | 3.87B |
| Pulike Biological Engineering | 4.26B |
| Guanhao Biotech | 3.86B |
| Qingdao Vland Biotech INC. | 3.83B |
| Hefei Lifeon Pharmaceutical | 4.30B |
| Shanghai Serum Bio-Technology | 3.80B |